Sold Out
Book Categories |
Acceptance Sampling | 1 | |
Active Control Trials | 9 | |
Adaptive Survival Trials | 16 | |
Adjustment for Covariates | 18 | |
Adverse Event Reporting | 22 | |
Ames Test | 28 | |
Analysis of Heritability | 36 | |
Analysis of Variance | 42 | |
Assay Development | 55 | |
Assay Validation | 63 | |
Bayesian Statistics | 72 | |
Bioassay | 80 | |
Bioavailability and Bioequivalence | 83 | |
Biologics | 89 | |
Biopharmaceutics | 100 | |
Blinding | 121 | |
Bootstrap, The | 127 | |
Bracketing Design | 133 | |
Bridging Studies | 134 | |
Calibration | 139 | |
Canadian Health Products and Food Branch (HPFB) and Therapeutic Products Directorate (TPD) | 147 | |
Cancer Trials | 152 | |
Carcinogenicity Studies of Pharmaceuticals | 160 | |
Carry-Foward Analysis | 175 | |
Clinical Data Management | 181 | |
Clinical Endpoint | 189 | |
Clinical Pharmacology | 193 | |
Clinical Trial Process | 196 | |
Clinical Trial Simulation | 200 | |
Clinical Trials | 202 | |
Combination Drug Clinical Trial | 210 | |
Comparing Variabilities in Clinical Research | 214 | |
Confidence Interval and Hypothesis Testing | 231 | |
Confounding and Interaction | 235 | |
Content Uniformity | 241 | |
Contract Research Organization (CRO) | 244 | |
Cost-Effectiveness Analysis | 249 | |
Crossover Design | 255 | |
Cutoff Designs | 263 | |
Data Mining and Biopharmaceutical Research | 270 | |
Data Monitoring Committees (DMC) | 277 | |
Diagnostic Imaging | 288 | |
Dose Proportionality | 295 | |
Dose Response Analysis in Clinical Trials | 298 | |
Dose Response Study Design | 304 | |
Dropout | 311 | |
Drug Development | 317 | |
Enrichment Design | 324 | |
Equivalence Trials | 327 | |
Ethnic Factors | 333 | |
Expiration Dating Period | 336 | |
Exploratory Factor Analysis | 343 | |
Extra Variation Models | 349 | |
Factorial Designs | 364 | |
Food and Drug Administration | 379 | |
Generalizability Probability in Clinical Research | 386 | |
Generalized Estimating Equation | 390 | |
Global Database and System | 397 | |
Good Clinical Practice | 403 | |
Good Programming Practice | 410 | |
Good Statistics Practice | 417 | |
Group Sequential Methods | 423 | |
Hypothesis Testing | 433 | |
Imputation in Clinical Research | 437 | |
Imputation with Item Nonrespondents | 443 | |
In Vitro Bioequivalence Testing | 449 | |
In Vitro Dissolution Profile Comparison | 456 | |
In Vitro Micronucleus Test | 463 | |
Individual Bioequivalence | 468 | |
Instrument Development and Validation | 476 | |
Integrated Summary Report | 486 | |
Intention-to-Treat Analyses (ITT) | 490 | |
Interactive Voice Randomization System (IVRS) | 494 | |
Interim Analysis | 502 | |
International Conference on Harmonization (ICH) | 508 | |
Investigating Quality-of-Life in Clinical Trials | 512 | |
Kaplan-Meier Estimator | 518 | |
Laboratory Analyses | 524 | |
Lilly Reference Ranges | 532 | |
Logistic Regression | 548 | |
Maximum Tolerable Dose for Cancer Chemotherapy | 554 | |
Measuring Agreement | 561 | |
MedDRA and Its Impact on Pharmaceutical Development | 568 | |
Medical Devices | 574 | |
Meta-Analysis of Therapeutic Trials | 586 | |
Microarray Gene Expression | 599 | |
Minimization Procedure | 614 | |
Minimum Effective Dose | 619 | |
Ministry of Health, Labour and Welfare and Pharmaceutical Administration in Japan | 622 | |
Mixed Effects Models | 630 | |
Multicenter Trials | 635 | |
Multinational Clinical Trial | 639 | |
Multiple Comparisons | 647 | |
Multiple-Dose Bioequivalence Studies | 652 | |
Multiple Endpoints | 656 | |
Multiplicity in Clinical Trials | 666 | |
Noninferiority Analysis in Active Controlled Clinical Trials | 674 | |
Odds Ratio | 678 | |
P-Values | 685 | |
P-Values, Evidence and Multiplicity Considerations for Controlled Clinical Trials | 696 | |
Parallel Design | 707 | |
Patient Compliance | 712 | |
Pharmacodynamic Issues | 718 | |
Pharmacodynamics with Covariates | 727 | |
Pharmacodynamics with No Covariates | 740 | |
Pharmacoeconomics | 749 | |
Placebo Effect | 764 | |
Population Bioequivalence | 769 | |
Postmarketing Adverse Drug Event Signaling | 776 | |
Postmarketing Surveillance | 790 | |
Power | 798 | |
Process Validation | 800 | |
Proportional Hazards Regression Model | 816 | |
Protocol Development | 824 | |
Randomization | 828 | |
Release Targets | 833 | |
Reproducibility Probability in Clinical Research | 838 | |
Reproductive/Developmental Studies | 850 | |
Response Surface Methodology | 858 | |
Robust Analysis for Crossover Design | 870 | |
ROC Curve | 884 | |
Sample Size Calculation for Survival Data | 892 | |
Sample Size Determination | 899 | |
Sample Size Re-estimation Based on Observed Treatment Difference | 915 | |
Screening Design | 920 | |
Selection of Control in Clinical Trials | 921 | |
Specifications | 927 | |
Stability Analysis for Frozen Drug Products | 929 | |
Stability Matrix Designs | 934 | |
Statistical Principles for Clinical Trials | 940 | |
Statistical Process Control | 945 | |
Statistical Significance | 954 | |
Subgroup Analysis | 959 | |
Surrogate Endpoint | 967 | |
Survival Analysis | 972 | |
Therapeutic Equivalence | 977 | |
Titration Design | 983 | |
Toxicological Studies | 988 | |
USP Tests | 1003 | |
Vaccine Clinical Trials | 1005 | |
Validity of LOCF | 1023 |
Login|Complaints|Blog|Games|Digital Media|Souls|Obituary|Contact Us|FAQ
CAN'T FIND WHAT YOU'RE LOOKING FOR? CLICK HERE!!! X
You must be logged in to add to WishlistX
This item is in your Wish ListX
This item is in your CollectionEncyclopedia of Biopharmaceutical Statistics, Second Edition
X
This Item is in Your InventoryEncyclopedia of Biopharmaceutical Statistics, Second Edition
X
You must be logged in to review the productsX
X
X
Add Encyclopedia of Biopharmaceutical Statistics, Second Edition, The only encyclopedia that specifically focuses on biopharmaceutical statistics, the 3rd Edition provides a well-balanced summary of current regulatory requirements, along with a comprehensive and unified presentation of designs and analyses used at diffe, Encyclopedia of Biopharmaceutical Statistics, Second Edition to the inventory that you are selling on WonderClubX
X
Add Encyclopedia of Biopharmaceutical Statistics, Second Edition, The only encyclopedia that specifically focuses on biopharmaceutical statistics, the 3rd Edition provides a well-balanced summary of current regulatory requirements, along with a comprehensive and unified presentation of designs and analyses used at diffe, Encyclopedia of Biopharmaceutical Statistics, Second Edition to your collection on WonderClub |